<![CDATA[Neoadjuvant Radiation May Improve Tolerability in Cholangiocarcinoma]]>

Summary

Dr. Ethan B. Ludmir discusses the rationale for using neoadjuvant radiation in borderline resectable cholangiocarcinoma to improve treatment tolerability. This is a clinical perspective article without specific trial data, company information, or regulatory catalysts.